Lionsgate director receives 6,828-share equity grant
SLOAN HARRY reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
SLOAN HARRY reported acquisition or exercise transactions in this Form 4 filing.
Lionsgate Studios Corp. director Harry Sloan received a grant of 6,828 common shares on April 1, 2026 as director fees, valued at $9.52 per share. Following this award, he directly holds 415,913 common shares, including 20,107 restricted share units scheduled to vest on November 28, 2026.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 6,828 | $9.52 | $65K |
Footnotes (2)
- F1. Director fees paid in common shares.
- F2. Amount includes 20,107 restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer, that are scheduled to vest on November 28, 2026.
Key Figures
Key Terms
director fees financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Lionsgate Studios Corp. (LION) report for Harry Sloan?
Was Harry Sloan’s Form 4 transaction in LION a purchase or a grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.